Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. The usefulness of extensive and repetitive surgery for ...
Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...
Using minimally invasive surgery and blood tests Break Through Cancer TeamLab found cancer cells, new drug targets, and biological clues for future therapies Researchers used a minimally invasive ...
This Ovarian Cancer Awareness Month, we share the story of Irene Koulogeorgiou, a 51-year-old Bulleen mother whose quick ...
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
"Don't ignore symptoms, even the smallest one." Irene Koulogeorgiou's story highlights the silent nature of ovarian cancer and the importance of persistence in seeking answers ...
Medical Xpress on MSN
Overcoming ovarian cancer's resistance to immunotherapy
Cells in our immune system are best known for providing security against external invaders such as bacteria and viruses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results